...
ADPTMID

Adaptive Biotechnologies Corporation

HealthcareBiotechnology
$16.44
$0.01(+4.71%)
52W$6.26
$20.76
FinancialsValuationvs CAI
Updated Mar 5, 12:00 AM
RSI46
RS Rating67/99
Beta1.31
Volatility73%
F-Score4/9
Mkt Cap$2.5B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Adaptive Biotechnologies Corporation shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 67), indicating performance broadly in line with the market. Earnings growth of 127% provides fundamental context to the price action. Investors should exercise caution due to high volatility (73% annualized), which requires wider risk management.

Relative Strength
67
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.31
vs S&P 500
ABOVE MKT
52W Position
70%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$16.87
50 SMA > 100 SMA$16.67
100 SMA > 150 SMA$15.41
150 SMA > 200 SMA$14.19

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$16.00+2.78%ABOVE
50 SMA$16.87-2.58%BELOW
100 SMA$16.67-1.37%BELOW
150 SMA$15.41+6.66%ABOVE
200 SMA$14.19+15.87%ABOVE

Price Performance

1D+4.7%
1W-0.1%
1M-0.2%
3M+11.5%
6M+27.9%
YTD+3.3%
1Y+104.7%
3Y+24.8%
52-Week Trading Range70% from low
$16.44
52W Low$6.26
52W High$20.76

Technical Indicators

RSI (14)NEUTRAL
46.2
305070
VCP ScoreCOOL
6/10
Base depth: 31.8%

Risk Profile

Beta
1.31
52W Vol
73%
ATR
$0.71
Max DD (1Y)
-28%

Volume Analysis

Today
1.33M
50D Avg
1.80M
Vol Ratio
0.74x
Liquidity
MODERATE

Earnings Momentum

Q4'24+52%
$-0.23
Q1'25+39%
$-0.20
Q2'25+45%
$-0.17
Q3'25+127%
$0.06
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:+16.04%
3 Years:+5.06%
TTM:+42.57%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:+59.59%

Stock Price CAGR

10 Years:-8.58%
5 Years:-17.20%
3 Years:+24.79%
1 Year:+104.73%

Return on Equity

10Y Avg:-42.5%
5Y Avg:-42.3%
3Y Avg:-52.8%
Last Year:-39.0%

Key Metrics

Market Cap$2.5B
Gross Margin59.7%
Net Margin-89.1%
Piotroski F-Score4/9

More ADPT Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

ADPT vs CAICAIVCYTNAUTCDIO

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 67 meansADPT outperformed 67% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 1.31 means 31% more volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 4/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with COOL status.

Frequently Asked Questions

Is ADPT in an uptrend right now?

ADPT has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is ADPT overbought or oversold?

ADPT's RSI (14) is 46. The stock is in neutral territory, neither overbought nor oversold.

Is ADPT outperforming the market?

ADPT has a Relative Strength (RS) Rating of 67 out of 99. ADPT is performing about average compared to the market.

Where is ADPT in its 52-week range?

ADPT is trading at $16.44, which is 79% of its 52-week high ($20.76) and 70% above its 52-week low ($6.26).

How volatile is ADPT?

ADPT has a Beta of 1.31 and 52-week volatility of 73%. It's more volatile than the S&P 500 - expect bigger swings.